Jinko provides personalized supportive care to cancer patients and aims to use the funds to expand partnerships, increase awareness among patients and medical professionals, and strengthen its digital applications.
Cancer patients who followed Jinko’s individualized care plan reported an average 38% improvement in quality of life after three months of the pilot phase | NCI on Unsplash
360 Capital, a French venture capital firm that invests in early-stage innovative deep tech and digital companies across Europe, has led a €2 million funding round for Jinko, a French startup that aims to improve the quality of life for cancer patients. AFI Ventures, the impact unit of early-stage digital venture capitalist Ventech, also participated in the round, along with 10 unnamed business angels from the healthcare, entrepreneurial, insurance and pharmaceutical sectors.
Faustin Auceda-Bouvier, a former executive at French telecoms giant Orange Group, co-founded Jinko last year with Anthony Miocec, former chief product officer at French workplace company Comet Meetings, after being inspired by a close friend battling cancer.
Jinco offers a multidisciplinary approach to care for cancer patients, which includes creating digital personalized plans that connect patients with dietary counseling, psychology, adaptive physical activity, osteopathic therapy and other specialist and medical support.
“Supportive care remains an under-addressed problem today and we believe the company’s approach will benefit many people,” said Clara Cornu, a partner at 360 Capital.
More than eight in 10 cancer patients experience physical or psychological effects related to their cancer or its treatment, but Zinko said a growing body of scientific research has shown how effective supportive care can be in reducing mortality, recurrence and side effects.
Mamadou Dembele, a senior associate at AFI Ventures, said he was “impressed” with Jinko’s vision to tackle a market “where digital solutions are limited.” Jinko’s holistic approach, integrating technology with a range of human support services, convinced AFI it was “the right strategy for this underserved sector,” Dembele said.
Quality of life
Jinko aims to use the funds to expand partnerships, increase awareness among patients and medical professionals, and strengthen its digital applications.
“Our goal is to support 1,000 patients over the next 12 months and continue to innovate to provide high-quality care during and after cancer treatment,” said co-founder Auseda Bouvier.
According to Jinko, cancer patients who followed the company’s individualized care plans in the trial phase reported an average 38% improvement in quality of life after three months.
Latest Articles
Post in category:
Funds,
Impact on the ecosystem,
investment
Post in category:
Funds,
Impact on the ecosystem,
investment
Post in category:
health care,
investment,
Venture Capital
Post in category:
health care,
investment,
Venture Capital
